
Sign up to save your podcasts
Or
Introducing Leading Through Setbacks with Cytokinetics’ Robert Blum from Clinical Trialblazers.
Follow the show: Clinical Trialblazers
In this episode of Clinical Trialblazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on muscle biology. Robert shares the values that guide his leadership style and how to move forward after failing.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
4.6
2828 ratings
Introducing Leading Through Setbacks with Cytokinetics’ Robert Blum from Clinical Trialblazers.
Follow the show: Clinical Trialblazers
In this episode of Clinical Trialblazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on muscle biology. Robert shares the values that guide his leadership style and how to move forward after failing.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
394 Listeners
305 Listeners
264 Listeners
193 Listeners
1,930 Listeners
522 Listeners
265 Listeners
298 Listeners
921 Listeners
38 Listeners
1,037 Listeners
13 Listeners
45 Listeners
44 Listeners
424 Listeners
705 Listeners
34 Listeners
7 Listeners
11 Listeners
13 Listeners
4 Listeners
5 Listeners
25 Listeners
10 Listeners
216 Listeners
5 Listeners
182 Listeners
14 Listeners
35 Listeners
34 Listeners
4 Listeners